Patent · US Active

Abuse deterrent opioid agonist transdermal compositions and methods for their use

US9895384B1 · kind B1 · utility

1Cited by
1References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 1, 2016
Grant dateFeb 20, 2018
Priority date—
Expiry dateApr 1, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F7/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure is directed to abuse-resistant transdermal delivery compositions comprising opioid agonists.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.